Human Longevity, Inc. Enhances $1 Million Initiative for Late-Stage Ovarian Cancer Prevention Human Longevity, Inc. expands its $1 million cancer prevention initiative to include late-stage ovarian cancer, promoting early detection and treatment.

Human Longevity, Inc. Enhances $1 Million Initiative for Late-Stage Ovarian Cancer Prevention #USA #South_San_Francisco #Human_Longevity #Ovarian_Cancer #Avantect

Human Longevity, Inc. Enhances Cancer Prevention with Avantect Test for Early Detection of Pancreatic Cancer Human Longevity, Inc. announces a significant expansion in cancer prevention with the integration of the Avantect test, enhancing early pancreatic cancer detection.

Human Longevity, Inc. Enhances Cancer Prevention with Avantect Test for Early Detection of Pancreatic Cancer #USA #pancreatic_cancer #South_San_Francisco #Human_Longevity #Avantect

Join ClearNote Health at Digestive Disease Week (#DDW) in San Diego May 406, where we’ll be showcasing the #Avantect Pancreatic Cancer Test - a groundbreaking epigenomic liquid biopsy designed to aid in the early detection of pancreatic cancer.

Visit us at booth 5525